Seres Therapeutics, Inc. (MCRB) by event type
MCRB moves most on analyst upgrades — a median of +2.71% at 30 minutes across 11 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the MCRB overview →
How MCRB reacts across 3 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 14 of 2,717 | 11 | +2.71% | 64% | +2.25% |
| Analyst downgrades 2,125 of 2,603 | 16 | -0.40% | 44% | -5.61% |
| Rating reiterations 3,496 of 3,522 | 25 | -1.52% | 24% | 0.00% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 3 further classes were observed with fewer than 10 measured events and are not published.
That’s how MCRB usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Rating reiterations → · MCRB overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Trinity Biotech plc - American Depositary Shares (TRIB) | 292 | -0.13% | 44% |
| CRISPR Therapeutics AG - Common Shares (CRSP) | 291 | +0.10% | 53% |
| Accuray Incorporated (ARAY) | 288 | 0.00% | 51% |
| Chemed Corp (CHE) | 288 | +0.02% | 53% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.